We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

139 hedge funds and large institutions have $231M invested in Spectrum Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $321K | Put options by funds: $239K

17% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 41

3% less funds holding

Funds holding: 144139 (-5)

12% less capital invested

Capital invested by funds: $264M → $231M (-$32.9M)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
139
Holders Change
-5
Holders Change %
-3.47%
% of All Funds
3.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
48
Reduced
41
Closed
22
Calls
$321K
Puts
$239K
Net Calls
+$82K
Net Calls Change
-$290K

SPPI Hedge Fund Activity: Q4 2016 in Review

139 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2016, worth a combined $231M — down 12% from $264M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 48 added.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.64M. The largest seller was Fidelity Investments, cutting an estimated $11.9M.

  • 139 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2016, down from 144 in Q3 2016.
  • Funds reported $231M of Spectrum Pharmaceuticals Inc stock for Q4 2016, down 12% quarter-over-quarter.
  • 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2016 and 22 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $4.64M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2016 was Fidelity Investments, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2016.